HIGH QUALITY SERVICE

high technology innovation , high speed development.

HIGH QUALITY SERVICE

食管癌 TMA

上海芯超生物科技有限公司 
生物芯片上海国家工程研究中心

上海市高新技術企業

  • 上海芯超生物科技有限公司成立於2003年12月18日
  • 為美國BIOXXX 組織晶片公司之上游供應商

擁有十五863消化道腫瘤組織庫與組織芯片重大項目、十一五863胰腺癌基因組重大項目、衛生部肝癌組織芯片分子標記物篩選重大項目、863胃癌易感基因與幽門螺桿菌耐藥基因聯合檢測重點項目。

商品介紹

Catalog

Diameter

Dots

Cases

Description

HEsoC050PT01

2.0mm

50

29

29 cases of esophagus squamous cell carcinoma（21 cases tumor with matched NAT, 1 core/case; 8 cases tumor tissue 1 core/case):squamous cell carcinomas,basal cell squamous carcinoma,  spindle cell squamous carcinoma,adenocarcinoma,  adenosquamous carconoma,undifferentiated carcinoma.

HEsoS030PG02

2.0mm

60

30

esophagus squamous cell carcinoma 30 cases: 1 core/case, grade I-Ⅲ.

HEsoS030PG03

2.0mm

30

15

1.Esophagus squamous cell carcinoma (15 cases),  tumor (1 core/case) and matched normal adjacent tissue (1 core/case).   Pathology grade 2.
2.Reproduce of HEso-Squ030PG-01

HEsoS045Ly01

2.0mm

45

15

esophagus squamous cell carcinoma 15 cases, tumor/NAT/lymph node.  Clinical stage

HEsoS060CS01

2.0mm

60

31

2 cases of normal esophageal.Esophagus squamous cell carcinoma 29 cases,tumor and NAT 1 core/case. Clinical stage 1,2,3,4 (Version 7.0).with TNM score.

HEsoS090PG01

1.5mm

90

30

esophagus squamous cell carcinoma 30 cases:tumor/NAT/remote tissue.Pathology grade  I-Ⅲ.

HEsoS180Su04

1.5mm

180

100

1. Esophagus squamous cell carcinoma (100 cases), 80 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 20 cases have tumor tissue (1 cores/case). 
2. Clinical stage I-Ⅲ(Version 7.0). 
3. Survival information available. Surgery date 2006.7-2008.12, visit date 2014.9. Being followed up for 5.8-7.8 years.
4.duplicate of HEso-Squ180Sur-01

HEsoS180Su06

1.5mm

180

103

203 cases esophagus squamous carcinoma with survival information, 103 cores of tumor and 77 cores of matched NAT.  Surgery date2 011.1－2013.4，visit date 2014.11. Being followed up for 1.6－3.8 years.

HEso-Squ030PG-01

2.0mm

30

15

1. Esophagus squamous cell carcinoma (15 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 
2.Pathology grade 2

HEso-Squ060CD-01

2.0mm

60

43

1. Progession of Esophageal cancer: normal esophagus mucosa tissue ,esophageal carcinoma in situ, primary focus of esophageal cancer( Clinical stage I-IV),adjacent mucosa tissue, metastases of esophageal cancer, negative lymph node, positive lymph node.
 2. 43 cases, 1 core/case 

HEso-Squ060PG-01

2.0mm

60

30

1. Esophagus squamous cell carcinoma (30 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 
2. Pathology grade 1 (3 cases), 1-2 (3 cases),  2 (13 cases), 2-3 (3 cases),  3 (8 cases).

HEso-Squ127Lym-01

1.5mm

127

50

1. Esophagus squamous cell carcinoma (50 cases), 27 cases have tumor(1 core/case) and matched normal adjacent tissue (1 core/case) and negative/positive lymph node (1 core/case), 23 cases have tumor tissue (1 core/case) and positive lymph node (1 core/case).  
2. Clinical stage N0(10 cases), N1a (20 cases), N1b (12 cases), N2 (4 cases), N3 (4 cases).

HEso-Squ150CS-02

1.5mm

150

75

1.75 cases of  Esophagus squamous cell carcinoma  with matched adjacent normal tissue, 1 core/case.
2.Clinical stage(AJCC 7.0)I  II III  IV, with TNM score.

HEso-Squ172Sur-02

1.5mm

172

93

1. Esophagus squamous cell carcinoma (93 cases),  79 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 14 cases have tumor tissue (1 core/case). 
2. Clinical stage I-Ⅲ (Version 7.0). 
3. Survival information available. Surgery date 2009.1-2010.1, visit date 2012.11. Being followed up for 3-4 yeas 

HEso-Squ180Sur-01

1.5mm

180

95

1. Esophagus squamous cell carcinoma (95 cases), 85 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 10 cases have tumor tissue (1 cores/case). 
2. Clinical stage I-Ⅲ(Version 7.0). 
3. Survival information available. Surgery date 2006.1-2008.10, visit date 2013.9. Being followed up for 4.8-6.8 years. (76 cases overlapped with HEso-Squ172Sur-01 )
4. follow up updated 2015.07   

HEso-Squ180Sur-02

1.5mm

180

90

1. Esophagus squamous cell carcinoma (90 cases), 85 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case).   
2. Clinical stage I-Ⅲ(Version 7.0). 
3. Survival information available. Surgery date 2009.1-2010.12, visit date 2013.9. Being followed up for 2.8-4.7 years. (51 cases overlapped with HEso-Squ172Sur-01 )

HEso-Squ180Sur-03

1.5mm

180

90

1. Esophagus squamous cell carcinoma (90 cases),  90 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 
2. Clinical stage I-Ⅲ (Version 7.0). 
3. Survival information available. Surgery date 2009.1-2010.12, visit date 2014.9. Being followed up for 4.8-6.7 years 
4. follow up updated  2015.07

OD-CT-DgEso01-004

1.5mm

184

92

1. Esophagus squamous cell carcinoma (92 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 
2. Clinical stage I-IV (Version 7.0).  
3.  60% cases have TNM detail information.
4.  Pathology grade 1, 2, 3.

OD-CT-DgEso02-001

2.0mm

32

32

1. Esophagus squamous cell carcinoma (32 cases), 1 core/case. 
2. Pathology grade 1.

OD-CT-DgEso02-002

2.0mm

32

32

1. Esophagus squamous cell carcinoma (32 cases), 1 core/case.  
2. Pathology grade 2.

OD-CT-DgEso02-003

2.0mm

32

32

1. Esophagus squamous cell carcinoma (32 cases), 1 core/case. 
2. Pathology grade 2-3, 3.

OD-CT-DgEso03-002

2.0mm

62

31

1. Esophagus squamous cell carcinoma (31 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case).  
2. Clinical stage II, III, IV (Version 7.0). 
3. 60% cases have TNM detail information.  
4. Pathology grade 1, 1-2.

OD-CT-DgEso03-003

2.0mm

62

31

1. Esophagus carcinoma (21 cases), containing squamous cell carcinoma (9 cases),  adenocarcinoma (5 cases),  small cell carcinoma ( 6 cases) and undifferentiated carcinoma (1 case). Esophagogastric junction carcinoma (8 cases).  Gastric carcinoma (2 cases).  
2. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).

OD-CT-DgEso04-001

1.5mm

85

40

1. Esophagus squamous cell carcinoma (40 cases), 2 cores/case.  Normal adjacent tissue (5 cases), 1 core/case. 
2. Clinical stage I, II, III (Version 7.0). 
3. 100% cases have TNM detail information. 
4. Pathology grade 1, 2, 3.

OD-CT-DgEso04-002

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case.  
2. Pathology grade 1 ( 39 cases),  1-2(6 cases).

OD-CT-DgEso04-003

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case. 
2.  Pathology grade 2. 

OD-CT-DgEso04-004

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case.  
2. Clinical stage II, III, IV (Version 7.0).
3.  50% cases have TNM detail information.
4.  Pathology grade 2-3, 3.

OD-CT-DgEso04-005

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case. 
2.  Pathology grade 2. 

OD-CT-DgEso04-006

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case. 
2. Clinical stage II, III (Version 7.0).
3. 60% cases have TNM detail information.  
4.  Pathology grade 2. 

OD-CT-DgEso04-007

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case. 
2.  Pathology grade 1, 1-2, 2, 2-3, 3.

OD-CT-DgEso04-008

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case.  
2. Clinical stage II, III, IV (Version 7.0). 
3.  70% cases have TNM detail information.
4.  Pathology grade 1, 1-2, 2.

OD-CT-DgEso04-009

2.0mm

45

45

1. Esophagus squamous cell carcinoma (45 cases), 1 core/case.  
2. Pathology grade 1, 2, 3.